1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Atherosclerosis Market, By Stage
5.1 Introduction
5.2 Plaque Growth
5.3 Plaque Rupture
5.4 Endothelial Damage and Immune Response
5.5 Fatty Streak
5.6 Other Stages
6 Global Atherosclerosis Market, By Treatment
6.1 Introduction
6.2 Medication
6.2.1 Beta Blockers
6.2.2 Angiotensin-Converting Enzyme (Ace) Inhibitors
6.2.3 Calcium Channel Blockers
6.2.4 Anti-Platelet Drugs
6.2.5 Cholesterol Lowering Medications
6.3 Surgery
6.3.1 Fibrinolytic therapy
6.3.2 Endarterectomy
6.3.3 Coronary artery bypass surgery
6.3.4 Angioplasty
6.4 Other Treatments
7 Global Atherosclerosis Market, By Route of Administration
7.1 Introduction
7.2 Parenteral
7.3 Oral
8 Global Atherosclerosis Market, By Distribution Channel
8.1 Introduction
8.2 Retail Pharmacy
8.3 Online Pharmacy
9 Global Atherosclerosis Market, By Diagnosis
9.1 Introduction
9.2 Doppler Ultrasound
9.3 Blood Tests
9.4 Ankle-brachial Index (ABI)
9.5 Echocardiogram
9.6 Electrocardiogram (ECG)
9.7 Other Diagnosis
10 Global Atherosclerosis Market, By End User
10.1 Introduction
10.2 Specialty Clinics
10.3 Homecare
10.4 Hospitals
10.5 Other End Users
11 Global Atherosclerosis Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Boehringer Ingelheim International GmbH.
13.2 Bayer AG
13.3 Teva Pharmaceutical Industries Ltd.
13.4 Pfizer Inc.
13.5 Lupin
13.6 GlaxoSmithKline plc
13.7 Dr. Reddy’s Laboratories Ltd.
13.8 Allergan
13.9 F. Hoffmann-La Roche Ltd.
13.10 Novartis AG
13.11 Bristol-Myers Squibb Company
13.12 Sanofi
13.13 Allergan
13.14 Eli Lilly and Company
13.15 AbbVie Inc.
13.16 Amgen Inc.
13.17 Gilead Sciences, Inc.
13.18 Hikma Pharmaceuticals PLC
13.19 Johnson & Johnson Private Limited
13.20 AstraZeneca
13.21 Merck & Co., Inc.
13.22 Mylan N.V.
List of Tables
Table 1 Global Atherosclerosis Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Atherosclerosis Market Outlook, By Stage (2021-2030) ($MN)
Table 3 Global Atherosclerosis Market Outlook, By Plaque Growth (2021-2030) ($MN)
Table 4 Global Atherosclerosis Market Outlook, By Plaque Rupture (2021-2030) ($MN)
Table 5 Global Atherosclerosis Market Outlook, By Endothelial Damage and Immune Response (2021-2030) ($MN)
Table 6 Global Atherosclerosis Market Outlook, By Fatty Streak (2021-2030) ($MN)
Table 7 Global Atherosclerosis Market Outlook, By Other Stages (2021-2030) ($MN)
Table 8 Global Atherosclerosis Market Outlook, By Treatment (2021-2030) ($MN)
Table 9 Global Atherosclerosis Market Outlook, By Medication (2021-2030) ($MN)
Table 10 Global Atherosclerosis Market Outlook, By Beta Blockers (2021-2030) ($MN)
Table 11 Global Atherosclerosis Market Outlook, By Angiotensin-Converting Enzyme (Ace) Inhibitors (2021-2030) ($MN)
Table 12 Global Atherosclerosis Market Outlook, By Calcium Channel Blockers (2021-2030) ($MN)
Table 13 Global Atherosclerosis Market Outlook, By Anti-Platelet Drugs (2021-2030) ($MN)
Table 14 Global Atherosclerosis Market Outlook, By Cholesterol Lowering Medications (2021-2030) ($MN)
Table 15 Global Atherosclerosis Market Outlook, By Surgery (2021-2030) ($MN)
Table 16 Global Atherosclerosis Market Outlook, By Fibrinolytic therapy (2021-2030) ($MN)
Table 17 Global Atherosclerosis Market Outlook, By Endarterectomy (2021-2030) ($MN)
Table 18 Global Atherosclerosis Market Outlook, By Coronary artery bypass surgery (2021-2030) ($MN)
Table 19 Global Atherosclerosis Market Outlook, By Angioplasty (2021-2030) ($MN)
Table 20 Global Atherosclerosis Market Outlook, By Other Treatments (2021-2030) ($MN)
Table 21 Global Atherosclerosis Market Outlook, By Route of Administration (2021-2030) ($MN)
Table 22 Global Atherosclerosis Market Outlook, By Parenteral (2021-2030) ($MN)
Table 23 Global Atherosclerosis Market Outlook, By Oral (2021-2030) ($MN)
Table 24 Global Atherosclerosis Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 25 Global Atherosclerosis Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
Table 26 Global Atherosclerosis Market Outlook, By Online Pharmacy (2021-2030) ($MN)
Table 27 Global Atherosclerosis Market Outlook, By Diagnosis (2021-2030) ($MN)
Table 28 Global Atherosclerosis Market Outlook, By Doppler Ultrasound (2021-2030) ($MN)
Table 29 Global Atherosclerosis Market Outlook, By Blood Tests (2021-2030) ($MN)
Table 30 Global Atherosclerosis Market Outlook, By Ankle-brachial Index (ABI) (2021-2030) ($MN)
Table 31 Global Atherosclerosis Market Outlook, By Echocardiogram (2021-2030) ($MN)
Table 32 Global Atherosclerosis Market Outlook, By Electrocardiogram (ECG) (2021-2030) ($MN)
Table 33 Global Atherosclerosis Market Outlook, By Other Diagnosis (2021-2030) ($MN)
Table 34 Global Atherosclerosis Market Outlook, By End User (2021-2030) ($MN)
Table 35 Global Atherosclerosis Market Outlook, By Specialty Clinics (2021-2030) ($MN)
Table 36 Global Atherosclerosis Market Outlook, By Homecare (2021-2030) ($MN)
Table 37 Global Atherosclerosis Market Outlook, By Hospitals (2021-2030) ($MN)
Table 38 Global Atherosclerosis Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
